Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-01-17 Sale |
2024-01-19 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $19.5 | $78,000 | 9,278 (Direct) |
View |
2024-01-05 Sale |
2024-01-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $19.16 | $88,116 | 116,139 (Direct) |
View |
2023-12-27 Sale |
2023-12-29 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
125 | $24.5 | $3,063 | 129,060 (Direct) |
View |
2023-12-20 Sale |
2023-12-22 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $19.5 | $78,000 | 22,301 (Direct) |
View |
2023-12-13 Sale |
2023-12-15 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
12,000 | $19.5 | $234,000 | 59,248 (Direct) |
View |
2023-12-05 Sale |
2023-12-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $16.3 | $74,996 | 120,739 (Direct) |
View |
2023-12-06 Sale |
2023-12-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $16.11 | $165,628 | 153,892 (Direct) |
View |
2023-11-27 Sale |
2023-11-29 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
12,517 | $16.24 | $203,237 | 164,175 (Direct) |
View |
2023-11-22 Sale |
2023-11-27 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
14,372 | $15.37 | $220,906 | 339,298 (Direct) |
View |
2023-11-22 Sale |
2023-11-27 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
13,800 | $15 | $207,000 | 125,339 (Direct) |
View |
2023-11-01 Sale |
2023-11-03 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNOLOGY OFFICER |
970 | $10.46 | $10,149 | 0 (Direct) |
View |
2023-11-01 Sale |
2023-11-03 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
1,092 | $10.42 | $11,379 | 0 (Direct) |
View |
2023-09-06 Sale |
2023-09-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,961 | $15.06 | $59,637 | 341,320 (Direct) |
View |
2023-08-07 Sale |
2023-08-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $15.52 | $159,580 | 195,025 (Direct) |
View |
2023-07-28 Sale |
2023-08-01 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
5,478 | $18 | $98,604 | 383,381 (Direct) |
View |
2023-07-17 Sale |
2023-07-19 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
4,522 | $18.11 | $81,896 | 388,859 (Direct) |
View |
2023-07-06 Sale |
2023-07-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $16.66 | $171,284 | 205,308 (Direct) |
View |
2023-07-05 Sale |
2023-07-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $17.3 | $38,915 | 139,139 (Direct) |
View |
2023-07-03 Sale |
2023-07-05 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $18 | $180,000 | 393,381 (Direct) |
View |
2023-06-06 Sale |
2023-06-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $16.28 | $167,416 | 215,591 (Direct) |
View |
2023-06-05 Sale |
2023-06-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $16.26 | $36,576 | 141,389 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Pigot Timothy CHIEF COMMERCIAL OFFICER |
66,586 | $0 | 67,877 (Direct) |
View |
2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNOLOGY OFFICER |
66,586 | $0 | 66,586 (Direct) |
View |
2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
66,586 | $0 | 66,586 (Direct) |
View |
2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
66,586 | $0 | 66,586 (Direct) |
View |
2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
66,586 | $0 | 66,586 (Direct) |
View |
2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
66,586 | $0 | 66,586 (Direct) |
View |
2024-01-17 Exercise |
2024-01-19 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $1.74 | 9,278 (Direct) |
View |
2024-01-17 Exercise |
2024-01-19 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $0 | 9,278 (Direct) |
View |
2024-01-05 Exercise |
2024-01-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,400 | $1.74 | 116,139 (Direct) |
View |
2024-01-05 Exercise |
2024-01-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
3,200 | $2.14 | 116,139 (Direct) |
View |
2024-01-05 Exercise |
2024-01-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $0 | 116,139 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
2,889 | $13.49 | 2,889 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | Dable Habib J Director |
2,964 | $13.49 | 2,964 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
3,519 | $13.49 | 3,519 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
3,186 | $13.49 | 3,186 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
125 | $2.14 | 129,060 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
125 | $0 | 129,060 (Direct) |
View |
2023-12-13 Exercise |
2023-12-22 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $1.74 | 22,301 (Direct) |
View |
2023-12-20 Exercise |
2023-12-22 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $0 | 22,301 (Direct) |
View |
2023-12-13 Exercise |
2023-12-15 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
12,000 | $1.74 | 59,248 (Direct) |
View |
2023-12-13 Exercise |
2023-12-15 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
12,000 | $0 | 59,248 (Direct) |
View |
2023-12-05 Exercise |
2023-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,400 | $1.74 | 120,739 (Direct) |
View |
2023-12-05 Exercise |
2023-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
3,200 | $2.14 | 120,739 (Direct) |
View |
2023-12-05 Exercise |
2023-12-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $0 | 120,739 (Direct) |
View |
2023-12-06 Exercise |
2023-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,411 | $1.74 | 153,892 (Direct) |
View |
2023-12-06 Exercise |
2023-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,872 | $2.14 | 153,892 (Direct) |
View |
2023-12-06 Exercise |
2023-12-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 153,892 (Direct) |
View |
2023-11-27 Exercise |
2023-11-29 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 164,175 (Direct) |
View |
2023-11-27 Exercise |
2023-11-29 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,104 | $2.14 | 164,175 (Direct) |
View |
2023-11-27 Exercise |
2023-11-29 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
12,517 | $0 | 164,175 (Direct) |
View |
2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 339,298 (Direct) |
View |
2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
11,960 | $2.14 | 339,298 (Direct) |
View |
2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
14,372 | $0 | 339,298 (Direct) |
View |
2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,200 | $1.74 | 125,339 (Direct) |
View |
2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
9,600 | $2.14 | 125,339 (Direct) |
View |
2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
13,800 | $0 | 125,339 (Direct) |
View |
2023-09-06 Exercise |
2023-09-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 341,320 (Direct) |
View |
2023-09-06 Exercise |
2023-09-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
1,548 | $2.14 | 341,320 (Direct) |
View |
2023-09-06 Exercise |
2023-09-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,961 | $0 | 341,320 (Direct) |
View |
2023-08-07 Exercise |
2023-08-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 195,025 (Direct) |
View |
2023-08-07 Exercise |
2023-08-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 195,025 (Direct) |
View |
2023-08-07 Exercise |
2023-08-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 195,025 (Direct) |
View |
2023-07-28 Exercise |
2023-08-01 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
5,478 | $2.14 | 383,381 (Direct) |
View |
2023-07-28 Exercise |
2023-08-01 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
5,478 | $0 | 383,381 (Direct) |
View |
2023-07-17 Exercise |
2023-07-19 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
4,522 | $2.14 | 388,859 (Direct) |
View |
2023-07-17 Exercise |
2023-07-19 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
4,522 | $0 | 388,859 (Direct) |
View |
2023-07-10 Option Award |
2023-07-11 5:06 pm |
N/A 2033-07-09 |
Aerovate Therapeutics Inc. | AVTE | Dable Habib J Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-07-06 Exercise |
2023-07-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 205,308 (Direct) |
View |
2023-07-06 Exercise |
2023-07-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 205,308 (Direct) |
View |
2023-07-06 Exercise |
2023-07-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 205,308 (Direct) |
View |
2023-07-05 Exercise |
2023-07-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 139,139 (Direct) |
View |
2023-07-05 Exercise |
2023-07-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 139,139 (Direct) |
View |
2023-07-05 Exercise |
2023-07-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 139,139 (Direct) |
View |
2023-07-03 Exercise |
2023-07-05 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $2.14 | 393,381 (Direct) |
View |
2023-07-03 Exercise |
2023-07-05 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $0 | 393,381 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
2023-06-06 Exercise |
2023-06-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 215,591 (Direct) |
View |
2023-06-06 Exercise |
2023-06-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 215,591 (Direct) |
View |
2023-06-06 Exercise |
2023-06-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 215,591 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Resnick Joshua Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-06-05 Exercise |
2023-06-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 141,389 (Direct) |
View |
2023-06-05 Exercise |
2023-06-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 141,389 (Direct) |
View |
2023-06-05 Exercise |
2023-06-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 141,389 (Direct) |
View |